Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice

Clinical and Experimental Immunology

Volumn 150, Issue 1, 2007, Pages 189-197

  Ekerfelt, C ^a   Andersson, M ^a   Olausson, A ^a   Bergstrom S ^b   Hultman, P ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Arthritis; Borrelia burgdorferi; Cytokines interleukins; Immunoglobulins

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 12P70; INTERLEUKIN 4; MERCURY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HELPER CELL; HISTOPATHOLOGY; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ARTHRITIS, INFECTIOUS; BODY WEIGHT; BORRELIA BURGDORFERI; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; JOINTS; LYME DISEASE; LYMPH NODES; MERCURIC CHLORIDE; MICE; MICE, INBRED C3H; TH1 CELLS;

EID: 34548541686     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03474.x     Document Type: Article

References (64)

1. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998 352:557 65.
2. Stanek G, Strle F. Lyme borreliosis. Lancet 2003 362:1639 47.
3. Berglund J, Eitrem R, Ornstein K et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995 333:1319 24.
4. Ekerfelt C, Masreliez C, Svenvik M et al. Antibodies and T cell reactivity to Borrelia burgdorferi in asymptomatic population: a study of healthy blood donors in an inland district in the south-east of Sweden. Scand J Infect Dis 2001 33:806 8.
5. Ekerfelt C, Forsberg P, Svenvik M et al. Asymptomatic Borrelia seropositive individuals display the same incidence of Borrelia-specific interferon-gamma (IFN-γ)-secreting cells in blood patients with clinical Borrelia infection. Clin Exp Immunol 1999 115:498 502.
6. Kaiser R. Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol 1994 242:26 36.
7. Nocton JJ, Steere AC. Lyme disease. Adv Int Med 1995 40:69 115.
8. Oschmann P, Dorndorf W, Hornig C et al. Stages and syndromes of neuroborreliosis. Neurology 1998 245:262 72.
9. Vrethem M, Hellblom L, Widlund M et al. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand 2002 106:205 8.
10. Berglund JL, Stjernberg K, Ornstein K. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002 34:421 5.
11. Stricker RB, Lautin A, Burrascano JJ. Lyme disease: point/counterpoint. Exp Rev Anti Infect Ther 2005 3:155 65.
12. Frey M, Jaulhac B, Piemont Y et al. Detection of Borrelia burgdorferi DNA in muscles of patients with chronic myalgia related to Lyme disease. Am J Med 1998 104:591 4.
13. Oksi J, Marjamaki M, Nikoskelainen J et al. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann Med 1999 31:225 32.
14. Preac-Mursic V, Weber K, Pfister HW et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 1989 17:355 9.
15. Hemmer B, Pinilla C, Gran B et al. Cross-recognition of self antigens by Borrelia burgdorferi-specific T cells derived from the cerebrospinal fluid of a patient with CNS Lyme disease. VII International conference on Lyme borreliosis and other emerging tick-borne diseases, Munich, Germany, 1999.
16. Sigal LH. Immunologic mechanisms in Lyme neuroborreliosis: the potential role of autoimmunity and molecular mimicry. Semin Neurol 1997 17:63 8.
17. Wagner EF, Hanna N, Fast LD et al. Novel diversity in IL-4 mediated responses in resting human naive B-cell versus germinal center/memory B cells. J Immunol 2000 165:5573 9.
18. Wang G, Ojaimi C, Wu H et al. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 2002 186:782 91.
19. Forsberg P, Ernerudh J, Ekerfelt C et al. The outer surface proteins of Lyme disease Borrelia spirochaetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications. Clin Exp Immunol 1995 101:453 60.
20. Oksi J, Savolainen J, Pene J et al. Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis. Infect Immun 1996 64:3620 3.
21. Yin Z, Braun J, Neure L et al. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 1997 40:69 79.
22. Ekerfelt C, Ernerudh J, Bunikis J et al. Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-γ predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol 1997 79:155 62.
23. Ekerfelt C, Ernerudh J, Forsberg P et al. Augmented intrathecal secretion of interferon-γ in response to Borrelia garinii in neuroborreliosis. J Neuroimmunol 1998 89:177 81.
24. Widhe M, Ekerfelt C, Forsberg P et al. IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an IFN-γ predominated disease. Scand J Immunol 1998 47:575 81.
25. Grusell M, Widhe M, Ekerfelt C. Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J Neuroimmunol 2002 131:173 8.
26. Widhe M, Jarefors S, Ekerfelt C et al. Borrelia specific IFN-γ and IL-4 secretion in blood and CSF during the course of human Lyme borreliosis: relation to clinical outcome. J Infect Dis 2004 189:1881 91.
27. Wang W-Z, Fredriksson S, Sun J-B et al. Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi-reactive cells secreting interferon-γ. Scand J Immunol 1995 42:694 700.
28. Granström M. Borrelios/Lyme disease - serologi/diagnostik. Information Från Läkemedelsverket [Information from the Medical Products Agency] 1998 9:98.
29. Gross DM, Steere AC, Huber BT. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 1998 160:1022 8.
30. Kang I, Barthold SW, Persing DH et al. T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 1997 65:3107 11.
31. Anguita J, Rincón M, Samanta S et al. Borrelia burgdorferi-infected, interleukin-6 deficient mice have decreased Th2 responses and increased Lyme arthritis. J Infect Dis 1998 178:1512 5.
32. Brown CR, Reiner SL. Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect Immun 1999 67:3329 33.
33. Christe M, Rutti B, Brossard M. Cytokines (IL-4 and IFN-γ) and antibodies (IgE and IgG2a) produced in mice infected with Borrelia burgdorferi sensu stricto via nymphs of Ixodex ricinus ticks or syringe inoculations. Parasitol Res 2000 86:491 6.
34. Christopherson JA, Munson EL, England DM et al. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha. Clin Diagn Lab Immunol 2003 10:44 52.
35. Satoskar AR, Elizondo J, Monteforte GM et al. Interleukin-4-deficient BALB/c mice develop an enhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection. FEMS Microbiol Lett 2000 183:319 25.
36. Bagenstose LM, Salgame P, Monestier M. Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. Environ Health Perspectives 1999 107:807 10.
37. Goldman M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991 12:223 7.
38. Häggqvist B, Hultman P. Murine metal-induced autoimmunity: baseline and stimulated cytokine mRNA expression in genetically susceptible and resistant strains. Clin Exp Immunol 2001 126:157 64.
39. Johansson U, Sander B, Hultman P. Effects of murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmun 1997 10:347 55.
40. Mathieson PW. Mercury: god of Th2 cells? Clin Exp Immunol 1995 102:229 30.
41. Ochel M, Vohr HW, Pfeiffer C et al. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991 146:3006 11.
42. Prigent P, Saoudi A, Pannettier C et al. Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T-cells to produce interleukin-4. J Clin Invest 1995 96:1484 9.
43. Havarinasab S, Hultman P. Organic mercury compounds and mercury. Autoimmun Rev 2005 4:270 5.
44. Bagenstose LM, Mentink-Kane MM, Brittingham A et al. Mercury enhance susceptibility to murine leishmaniasis. Parasite Immunol 2001 23:633 40.
45. Morris L, Trout AB, McLeod KS et al. Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun 1993 61:3459 65.
46. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Ann Rev Immunol 1995 13:151 77.
47. Jarefors S, Janefjord CK, Forsberg P et al. Decreased up-regulation of the interleukin-12Rb2-chain and interferon-γ secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic individuals. Clin Exp Immunol 2006 147:18 27.
48. Jarefors S, Karlsson M, Forsberg P et al. Reduced numbers of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum. Clin Exp Immunol 2005 143:322 8.
49. Sjöwall J, Carlsson A, Vaarala O et al. Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-α and interleukin-12 in asymptomatic individuals in response to live spirochaetes. Clin Exp Immunol 2005 141:89 98.
50. Barthold SW, Beck DS, Hansen GM et al. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 1990 162:133 8.
51. Bergström S, Sjöstedt A, Dotevall L et al. Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components. Eur J Clin Microbiol Infect Dis 1991 10:422 7.
52. Hovden AO, Cox RJ, Madhun A et al. Two doses parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice. Scand J Immunol 2005 62:342 52.
53. Havarinasab S, Lambertsson L, Qvarnström J et al. Dose-response study of thimerosal-induced murine systemic immunity. Toxicol Appl Pharmacol 2004 194:169 79.
54. Finkelman FD, Holmes J, Katona IM et al. Lymphokine control of in vivo immunoglobuline isotype selection. Ann Rev Immunol 1990 8:303 33.
55. Kuhn R, Rajewski K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991 254:707 10.
56. Wynn TA. IL-13 effector functions. Annu Rev Immunol 2003 21:425 56.
57. Johansson U, Hansson-Georgiadis H, Hultman P. The genotype determines the B cell response in mercury-treated mice. Int Arch Allergy Immunol 1998 116:295 305.
58. Anguita J, Persing DH, Rincón M et al. Effect of anti-interleukin 12 treatment on murine Lyme borreliosis. J Clin Invest 1996 97:1028 34.
59. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997 18:478 82.
60. Wegmann TG, Lin H, Guilbert L et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993 14:353 6.
61. Moro MH, Bjornsson J, Marietta EV et al. Gestational attenuation of Lyme arthritis is mediated by progesterone and IL-4. J Immunol 2001 166:7404 9.
62. Ekerfelt C, Ernerudh J, Jenmalm MC. Detection of spontaneous and antigen-induced human IL-4 responses in vitro; comparison of ELISPOT, a novel ELISA and real time RT-PCR. J Immunol Meth 2002 260:55 67.
63. Rönnelid J. Reactivity to collagen type II and C1q in rheumatic diseases. Stockholm, Sweden:Department of Medicine, Rheumatology Unit, Karolinska Institute, 1997.
64. Talkington J, Nickell SP. Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infect Immun 1999 67:1107 15.